外体circRNAs:乳腺癌进展中的关键调节器
Guozhen Liu1, Quan Liu2, Lingmei Jia3
1Department of Spinal Surgery, General Hospital of Ningxia Medical University, Yinchuan, China.
Cell death discovery
|April 24, 2025
概括
携带圆形RNAs (circRNAs) 的外体是乳腺癌 (BC) 细胞通信的关键,影响瘤生长和治疗耐药性. 这些外体 circRNAs 显示为BC.的诊断和治疗生物标志物具有前途.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 乳腺癌 (BC) 是一个全球性的健康挑战,需要更深入的理解.
- 外体是细胞外囊泡,通过携带的生物活性分子调解细胞间的通信.
- 循环RNAs (circRNAs) 是一种新型的RNA分子,可以调节基因表达和信号通路.
研究的目的:
- 审查外体circRNAs在乳腺癌进展中的作用和机制.
- 探索外体环RNAs作为BC.的诊断和治疗生物标志物的潜力.
主要方法:
- 文献综述侧重于乳腺癌中的外体环RNAs.
- 在外体内分析circRNA功能.
- 对诊断和治疗潜力的评估.
主要成果:
- 外体circRNAs在BC中促进细胞间通信,影响瘤进展,免疫逃避和耐药性.
- 包装在外体中的circRNAs作为BC和微环境细胞之间的遗传信息传递器.
- 外体环RNAs表现出稳定性和特异性,表明其作为生物标志物的潜力.
结论:
- 外体环RNA在BC进展和治疗反应中起着关键作用.
- 这些分子对BC诊断和治疗开发具有重大潜力.
- 对外体circRNA的进一步研究可能会彻底改变BC治疗模式并改善患者的治疗结果.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
MicroRNAs
21.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.0K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K


